Enzene Adds 26,000 Sq. Ft. to NJ Facility, Unveils Expansion at BIO 2025

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, announced that ahead of the official opening of its biologics manufactu...

June 17, 2025 | Tuesday | News
Integrated CMC workflows for current and next-generation ADCs

ADCs are no longer a niche modality. To date, there are over a dozen approved ADCs on the market, and more than 500 programs are in clinical development, d...

June 16, 2025 | Monday | Expert Opinion
Sarepta Halts ELEVIDYS Shipments for Non-Ambulatory Duchenne Patients After Second Fatal Case of Acute Liver Failure

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety update regarding ELEVIDYS (...

June 16, 2025 | Monday | News
Genmab’s Epcoritamab-R-ICE Combo Shows 87% Response Rate in High-Risk Relapsed DLBCL Patients Eligible for Stem Cell Transplant

Genmab A/S announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging bispeci...

June 16, 2025 | Monday | News
Sinovac’s Showdown: Board Fights Back Against Dissident Slate as $55/Share Dividend Hangs in Balance

Sinovac Biotech Ltd. (NASDAQ: SVA), a prominent player in China's biopharmaceutical sector, has entered a defining phase in its corporate history. As the...

June 13, 2025 | Friday | Reports
Cytiva Accelerates Bioprocessing Supply with $1.6B Global Manufacturing Expansion

  Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bag...

June 12, 2025 | Thursday | News
EDETEK Partners with Capgemini to Accelerate AI-Driven Digital Transformation in Clinical Development

  EDETEK Inc., a global provider of leading AI-driven clinical development platforms and services, has engaged Capgemini to support its ongoing advan...

June 11, 2025 | Wednesday | News
HepaRegeniX Doses First Patient in Phase Ib Trial of HRX-215 for Liver Regeneration After Colorectal Cancer Surgery

HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, announced that...

June 11, 2025 | Wednesday | News
XL-protein and Grifols Partner to Develop Novel Long-Acting Biopharmaceutical Using PASylation® Technology

XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced  that it has entered into a worldwide License, Dev...

June 11, 2025 | Wednesday | News
Sanofi Begins Early Q3 Shipments of Beyfortus to Meet Growing Demand for RSV Protection in Infants

Sanofi is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025-2026 respiratory syncytial virus (RSV)...

June 10, 2025 | Tuesday | News
Forging the Future of Biomanufacturing: How VVMF and Cytiva Are Elevating Australia’s Global Role

As the world recalibrates its life sciences infrastructure post-pandemic, Australia is stepping up as a regional powerhouse in biomanufacturing—espec...

June 05, 2025 | Thursday | Interaction
Trethera Secures Exclusive Worldwide License From UCLA to Expand TRE-515 Patent Protection

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

June 04, 2025 | Wednesday | News
CERo Therapeutics Expands Global Patent Portfolio With New U.S. and European Grants Covering Lead Candidate CER-1236

CERo Therapeutics Holdings, Inc,an innovative immunotherapy company seeking to advance the next generation of  engineered T cell therapeutics that d...

June 03, 2025 | Tuesday | News
Indaptus Therapeutics Doses First Patient in Decoy20 and Tislelizumab Combination Trial for Advanced Solid Tumors

Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infectio...

June 03, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close